Sensei Biotherapeutics, Inc. Profile Avatar - Palmy Investing

Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designe…

Biotechnology
US, Rockville [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Sensei Biotherapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of SNSE's Analysis
CIK: 1829802 CUSIP: 81728A108 ISIN: US81728A1088 LEI: - UEI: -
Secondary Listings
SNSE has no secondary listings inside our databases.